204 related articles for article (PubMed ID: 31502304)
1. Relationship between time-to-isolation and freeze duration: Computational modeling of dosing for Arctic Front Advance and Arctic Front Advance Pro cryoballoons.
Getman MK; Wissner E; Ranjan R; Lalonde JP
J Cardiovasc Electrophysiol; 2019 Nov; 30(11):2274-2282. PubMed ID: 31502304
[TBL] [Abstract][Full Text] [Related]
2. Catheter ablation using the third-generation cryoballoon provides an enhanced ability to assess time to pulmonary vein isolation facilitating the ablation strategy: Short- and long-term results of a multicenter study.
Aryana A; Kowalski M; O'Neill PG; Koo CH; Lim HW; Khan A; Hokanson RB; Bowers MR; Kenigsberg DN; Ellenbogen KA;
Heart Rhythm; 2016 Dec; 13(12):2306-2313. PubMed ID: 27503480
[TBL] [Abstract][Full Text] [Related]
3. Comparison of procedural efficacy and biophysical parameters between two competing cryoballoon technologies for pulmonary vein isolation: Insights from an initial multicenter experience.
Yap SC; Anic A; Breskovic T; Haas A; Bhagwandien RE; Jurisic Z; Szili-Torok T; Luik A
J Cardiovasc Electrophysiol; 2021 Mar; 32(3):580-587. PubMed ID: 33492749
[TBL] [Abstract][Full Text] [Related]
4. Durability of Pulmonary Vein Isolation with Cryoballoon Ablation: Results from the Sustained PV Isolation with Arctic Front Advance (SUPIR) Study.
Reddy VY; Sediva L; Petru J; Skoda J; Chovanec M; Chitovova Z; Di Stefano P; Rubin E; Dukkipati S; Neuzil P
J Cardiovasc Electrophysiol; 2015 May; 26(5):493-500. PubMed ID: 25644659
[TBL] [Abstract][Full Text] [Related]
5. The fourth cryoballoon generation with a shorter tip to facilitate real-time pulmonary vein potential recording: Feasibility and safety results.
Straube F; Dorwarth U; Pongratz J; Brück B; Wankerl M; Hartl S; Hoffmann E
J Cardiovasc Electrophysiol; 2019 Jun; 30(6):918-925. PubMed ID: 30907462
[TBL] [Abstract][Full Text] [Related]
6. Optimizing ablation duration using dormant conduction to reveal incomplete isolation with the second generation cryoballoon: A randomized controlled trial.
Keçe F; de Riva M; Naruse Y; Alizadeh Dehnavi R; Wijnmaalen AP; Schalij MJ; Zeppenfeld K; Trines SA
J Cardiovasc Electrophysiol; 2019 Jun; 30(6):902-909. PubMed ID: 30884006
[TBL] [Abstract][Full Text] [Related]
7. Procedural and biophysical indicators of durable pulmonary vein isolation during cryoballoon ablation of atrial fibrillation.
Aryana A; Mugnai G; Singh SM; Pujara DK; de Asmundis C; Singh SK; Bowers MR; Brugada P; d'Avila A; O'Neill PG; Chierchia GB
Heart Rhythm; 2016 Feb; 13(2):424-32. PubMed ID: 26520204
[TBL] [Abstract][Full Text] [Related]
8. Circulatory Dynamics During Pulmonary Vein Isolation Using the Second-Generation Cryoballoon.
Kajiyama T; Miyazaki S; Watanabe T; Yamao K; Kusa S; Igarashi M; Nakamura H; Hachiya H; Iesaka Y
J Am Heart Assoc; 2017 Oct; 6(10):. PubMed ID: 29018024
[TBL] [Abstract][Full Text] [Related]
9. Feasibility, safety, and acute efficacy of the fourth-generation cryoballoon for ablation of atrial fibrillation: Another step forward?
Rottner L; Mathew S; Reissmann B; Warneke L; Martin I; Lemes C; Maurer T; Wohlmuth P; Ouyang F; Kuck KH; Metzner A; Rillig A
Clin Cardiol; 2020 Apr; 43(4):394-400. PubMed ID: 32097501
[TBL] [Abstract][Full Text] [Related]
10. Comparison of procedural efficacy, balloon nadir temperature, and incidence of phrenic nerve palsy between two cryoballoon technologies for pulmonary vein isolation: A systematic review and meta-analysis.
Assaf A; Bhagwandien R; Szili-Torok T; Yap SC
J Cardiovasc Electrophysiol; 2021 Sep; 32(9):2424-2431. PubMed ID: 34289198
[TBL] [Abstract][Full Text] [Related]
11. Verification of a novel atrial fibrillation cryoablation dosing algorithm guided by time-to-pulmonary vein isolation: Results from the Cryo-DOSING Study (Cryoballoon-ablation DOSING Based on the Assessment of Time-to-Effect and Pulmonary Vein Isolation Guidance).
Aryana A; Kenigsberg DN; Kowalski M; Koo CH; Lim HW; O'Neill PG; Bowers MR; Hokanson RB; Ellenbogen KA;
Heart Rhythm; 2017 Sep; 14(9):1319-1325. PubMed ID: 28625929
[TBL] [Abstract][Full Text] [Related]
12. Predictors of durable electrical isolation in the setting of second-generation cryoballoon ablation: A comparison between left superior, left inferior, right superior, and right inferior pulmonary veins.
Scala O; Borio G; Paparella G; Varnavas V; Ströker E; Guimaraes Osorio T; Terasawa M; Sieira J; Maj R; Rizzo A; Al-Hosari MM; Galli A; Brugada P; de Asmundis C; Chierchia GB
J Cardiovasc Electrophysiol; 2020 Jan; 31(1):128-136. PubMed ID: 31749209
[TBL] [Abstract][Full Text] [Related]
13. Difference in tissue temperature change between two cryoballoons.
Hayashi T; Hamada K; Iwasaki K; Takada J; Murakami M; Saito S
Open Heart; 2023 Dec; 10(2):. PubMed ID: 38065585
[TBL] [Abstract][Full Text] [Related]
14. Dosing of the second-generation cryoballoon using acute time-to-pulmonary vein isolation as an indicator of durable ablation in a canine model.
Su W; Coulombe N; Kirchhof N; Grassl E; Wittenberger D
J Interv Card Electrophysiol; 2018 Dec; 53(3):293-300. PubMed ID: 29656325
[TBL] [Abstract][Full Text] [Related]
15. Atrial fibrillation cryoablation is an effective day case treatment: the UK PolarX vs. Arctic Front Advance experience.
Honarbakhsh S; Martin CA; Mesquita J; Herlekar R; Till R; Srinivasan NT; Duncan E; Leong F; Dulai R; Veasey R; Panikker S; Paisey J; Ramgopal B; Das M; Ahmed W; Sahu J; Earley MJ; Finlay MC; Schilling RJ; Hunter RJ
Europace; 2023 Nov; 25(11):. PubMed ID: 37738643
[TBL] [Abstract][Full Text] [Related]
16. Multicenter Study of the Validity of Additional Freeze Cycles for Cryoballoon Ablation in Patients With Paroxysmal Atrial Fibrillation: The AD-Balloon Study.
Miyamoto K; Doi A; Hasegawa K; Morita Y; Mishima T; Suzuki I; Kaseno K; Nakajima K; Kataoka N; Kamakura T; Wada M; Yamagata K; Ishibashi K; Inoue YY; Nagase S; Noda T; Aiba T; Asakura M; Izumi C; Noguchi T; Tada H; Takagi M; Yasuda S; Kusano KF
Circ Arrhythm Electrophysiol; 2019 Jan; 12(1):e006989. PubMed ID: 30626209
[TBL] [Abstract][Full Text] [Related]
17. The established and the challenger: A direct comparison of current cryoballoon technologies for pulmonary vein isolation.
Moser F; Rottner L; Moser J; Schleberger R; Lemoine M; Münkler P; Dinshaw L; Kirchhof P; Reissmann B; Ouyang F; Rillig A; Metzner A
J Cardiovasc Electrophysiol; 2022 Jan; 33(1):48-54. PubMed ID: 34766404
[TBL] [Abstract][Full Text] [Related]
18. Acute outcome after a single cryoballoon ablation: Comparison between Arctic Front Advance and Arctic Front Advance PRO.
Moltrasio M; Sicuso R; Fassini GM; Riva SI; Tundo F; Dello Russo A; Casella M; Majocchi B; Zucchetti M; Cellucci S; Tondo C
Pacing Clin Electrophysiol; 2019 Jul; 42(7):890-896. PubMed ID: 31046130
[TBL] [Abstract][Full Text] [Related]
19. PolarX Cryoballoon metrics predicting successful pulmonary vein isolation: targets for ablation of atrial fibrillation.
Honarbakhsh S; Earley MJ; Martin CA; Creta A; Sohaib A; Ang R; Butcher C; Waddingham PH; Dhinoja M; Lim W; Srinivasan NT; Providencia R; Kanthasamy V; Sporton S; Chow A; Lambiase PD; Schilling RJ; Finlay MC; Hunter RJ
Europace; 2022 Oct; 24(9):1420-1429. PubMed ID: 35737685
[TBL] [Abstract][Full Text] [Related]
20. A comparison of acute procedural outcomes within four generations of cryoballoon catheters utilized in the real-world multicenter experience of 1STOP.
Iacopino S; Pieragnoli P; Arena G; Sciarra L; Landolina M; Manfrin M; Verlato R; Solimene F; Sacchi R; Rebellato L; Rovaris G; Molon G; Infusino T; Tondo C
J Cardiovasc Electrophysiol; 2020 Jan; 31(1):80-88. PubMed ID: 31701569
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
